Authored by Zachary Stieber via The Epoch Times,
The Federal Trade Commission (FTC) is examining statements from several organizations that have promoted drugs and surgeries for minors who believe they are a different gender, according to documents made public on Feb. 10.
FTC officials sent civil demands for documents to the American Academy of Pediatrics and World Professional Association of Transgender Health, documentspostedonlineby the FTC show.
Officials asked for each type of pediatric gender dysphoria treatment that the organizations advertised or promoted and information on financial relationships between the organizations and pharmaceutical companies, hospitals, or doctors involved in treating gender dysphoria.
They also want to know about the process for how the American Academy of Pediatrics developed its 2018 statement outlining its position on care for youth labeled as “transgender,” and how the World Professional Association of Transgender Health came up with its Standards of Care Version 8, which contains guidance for doctors contemplating giving children puberty blockers or cross-sex hormones, or performing surgeries on children questioning their gender.
FTC Chairman Andrew Ferguson said in 2025 the agency wouldinvestigatewhether the gender transition procedures were being offered under unfair or false claims.
The inquiry islookinginto whether people, particularly children, were harmed by false or unsubstantiated claims about “gender-affirming care.”
The American Academy of Pediatrics said in a response to the civil demand, filed with the FTC, that the FTC was going beyond its scope in the probe and that the demand should be quashed.
The World Professional Association of Transgender Health issued a similar response in a petition to revoke the demand directed to it.
The FTC and the two groups did not respond to requests for comment by publication time. If the petitions are turned down, the groups could turn to the courts.
Source: ZeroHedge News
